Overview

Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care

Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The primary objective is to demonstrate the improvement in glycosylated haemoglobin (HbA1c) levels after general practitioner (GP) initiation and management of type 2 diabetes mellitus (T2DM) with insulin glargine compared with their usual clinical practice. The secondary objective is to demonstrate the importance of GP initiation of insulin glargine for the treatment of T2DM.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Hypoglycemic Agents
Insulin
Insulin Glargine
Insulin, Globin Zinc